Classification of Pharmaceutical
products and processing
 classification of pharmaceuticaldosage forms
 solids
 semi solids
 liquid forms
 gas forms
 solids maybe tablets and capsules.
 semi solids are in cream,gel or in pate form.
 liquid are in syrup or in solution form.
 gas maybe inhalers or in aerosol form.
SOLID FORM
oral solid dosage forms are some of the most popular and convenient methods of drug delivery.
They can be produced in a non-sterile environment with the high volume of products produced in these dosage forms.
TYPES OF SOLID DOSAGE FORMS
 TABLETS
 CAPSULES
 POWDER
 LOZENGES
TABLETS
 They are unit solid dosage forms consisting of the active ingredient and suitable
pharmaceutical expients.
They may vary in size, shape, weight, hardness, thickness, disintegration and characteristics
and in other aspects.
CAPSULES:
They are unit solid dosage forms of consisting of gelatin shell that breaks open after the
capsule has been swallowed and releasing the drug.
CAPSULES
 TYPES
 Hard-shell gelatin capsule
 Soft-shell gelatin capsule
 1. SOFT GELATIN;
 Manufactured in one piece with drug usually in liquid form
inside the shell e.g;fat soluble vitamins and E etc.
2. HARD SHELL
 Manufactured in two pieces that fit together and hold the drug, either in powdered or
granular form.
 LOZENGES
 Tablets formed from hardened base or sugar and water containing drug and other flavors.
 they are designed to dissolve slowly in the mouth and release the drug topically to the
tissues of mouth and throat they are not to be swallowed.
POWDER
 They are bulk solid dosage forms consisting of two or more medicament meant for internal use.
 The size of the powder determines the effective physiological properties.
SEMI-SOLID FORMS
They contain both liquid and solid dosage forms that are too soft in structure to quality for solids but too thick to
be considered liquid. They are meant for typical application.
PHARMACEUTICAL PROCESS
It is the formation of drugs which involves the unit operations.
Types of unit operation
i. Size reduction
ii. Blending
iii. Drying
iv. Tablet compression
v. Coating
vi. Dry granulation
Equipment’ s Used
i. Drying equipment
ii. Tablet machine
iii. quality control machine
iv. Coating machine
v. Granulator
vi. Weighting machine
vii. Mixing equipment’ s
viii. Size reduction equipment
Steps involved in tablet formation
 Active pharmaceutical ingredients are bulk drugs that are
pharmaceutically active and generate a desired pharmacological
effects.
Excipients:
 They are pharmaceutically inactive and they act as a carrier .
POWDER BLENDING
 Powder are mixed using a blender to obtain to obtain a uniform and
homogenous powder.
 A wide range of excipients may be blended to create the final blend
used to manufacture the solid dosage form in pharmaceutical industry.
GRANULATION PROCESS
 Granulation process transfers fine powder into the free flowing ,dust free
granules that are easy to compress.
 There are three methods of Granulations
 Wet Granulation
 Dry Granulations
 Direct Granulations
WET Granulations
 It is a widely used methods for the production of compressed.
 It is essentially a process of size enlargement
 Greater probability of meeting the physical requirements for tablet
formation
DRY GRANULATION
 The formation of granules by compacting powder mixtures into large
pieces or compacts which is subsequently broken down or sized into
granules is a possible granulation methods.
 It is not widely used methods.
 It is generally achieved by roller compaction.
DIRECT GRANULATION
 Direct Compression involves the direct compression of powdered
materials into tablets without modifying the physical nature of the
materials itself.
 It has great importance because it is cheapest ones.
 It also avoids many problems.
DRYING AND DRY SCREENING
 .Screened wet granules need to be dried for a particular time period in a
fluid bed dryer at controlled temperature not exceeding 55C.
 TABLET COMPRESSION :
 This step involves in the compression of granules into a flat or convex
,round or unique shaped tablets.
COATING
 Tablets are coated if there is need to mask the unpleasant taste or odour
of some drud substances.
Defects in compression tablets
i. Poor mixing
ii. Low hardness
iii. Weight variation
Synthesis Of
Paracetamol
Paracetamol also known
as acetaminophen or APAP, is a medicine used
to treat pain and fever. It is typically used for
mild to moderate pain relief. Evidence for its
use to relieve fever in children is mixed .It is often
sold in combination with other medications,
such as in many cold medications. In
combination with opioid pain medication,
paracetamol is also used for severe pain such
as cancer pain and pain after surgery .It is
typically used either by mouth or rectally, but is
also available intravenously .Effects last
between 2 and 4 hours.
Chemical properties
 Paracetamol molecule polar surface area
 Paracetamol electrostatic potential map
 Paracetamol consists of a benzene ring core, substituted by
one hydroxyl group and the nitrogen atom of an amide group in
the para (1,4) pattern.[The amide group is acetamide (Ethan amide). It is
an extensively conjugated system, as the lone pair on the hydroxyl
oxygen, the benzene pi cloud, the nitrogen lone pair, the p orbital on
the carbonyl carbon, and the lone pair on the carbonyl oxygen are all
conjugated. The presence of two activating groups also make the
benzene ring highly reactive toward electrophilic aromatic substitution. As
the substituents are ortho, para-directing and para with respect to each
other, all positions on the ring are more or less equally activated. The
conjugation also greatly reduces the basicity of the oxygen's and the
nitrogen, while making the hydroxyl acidic through delocalization of
charge developed on the phenoxide anion.
Synthesis of Paracetamol
In the laboratory, paracetamol is easily prepared by nitrating phenol
with sodium nitrate, separating the desired p-nitro phenol from
the ortho- byproduct, and reducing the nitro group with sodium boro
hydride. The resultant p-aminophenol is then acetylated with acetic
anhydride. In this reaction, phenol is strongly activating, thus the
reaction requires only mild conditions nitration The industrial process is
analogous, but hydrogenation is used instead of the sodium boro
hydride reduction
Procedure
1. Add 2.1 grams of 4-aminophenol into the round-
bottomed flask.
2. Using your 25 mL measuring cylinder, measure 18 mL of
water and add this to the flask.
Add a magnetic follower to the round-bottomed flask.
3. Carefully clamp the flask at the neck and position it in
the metal Dry Syn block which should be placed on the
stirrer hotplate. Stir the reaction mixture using a magnetic
follower. Do not apply heat at this stage
. 4-. Assemble the apparatus for reflux as shown in the
diagram below. Tip: Do not clamp the condenser
5. Using a Pasteur pipette, measure 3 mL of
ethanoic
anhydride (also known as acetic anhydride)
into a
10 mL measuring cylinder. Add this to your
mixture
by lifting the condenser and adding directly to
the
round-bottomed flask.
6. Replace the condenser and switch on the
heat to
your hotplate (set the dial to about 120°C).
Make sure there is water going through your
condenser.
7. The reaction is heated at reflux for 15 minutes,
stirring continuously. The reaction mixture should
become colorless.
8. After refluxing for 15 minutes, switch off the
heat
11. filter the precipitate (using a Buchner funnel),
washing with small amounts of cold, distilled water.
12. After drying, the crude product should be
placed in a clean 100cm3 conical flask and
recrystallized by heating until it just dissolves in
approximately 20ml of water.
Cool the flask in ice until crystals of the purified
paracetamol appear.
Filter the crystals under vacuum, dry in a warm oven
and then record the melting point and compare with
standard paracetamol tablets (~170oC). Repeat
recrystalisation process to achieve a more purer
product
Synthesis of Aspirin
 Aspirin act as an analgesic, antipyretic (Something that reduces fever or
quells it), Anti-inflammatory also inhibit platelet aggregation & prolongs
bleeding time, because of its effect on G.I.T(gastrointestinal tract) it is
contraindicated ( Anything (including a symptom or medical condition) that is a
reason for a person to not receive a particular treatment or procedure because it
may be harmful) in peptic ulcer, in this case we use paracetamol .
 Aspirin is not given to children because is may cause raye’s syndrome.
Introduction :
 Aspirin (acetyl salicylic acid) is a widely used drug in modern
society.
 Salicylic acid which is a constituent of certain plant is itself an
analgesic & was originally administered as sodium salicylate,
since salicylic acid has an irritating effect on the stomach,
chemists thought of a modification which would retain its
properties while decreasing the adverse side effects.
 Conversion to the ester satisfied this requirement& aspirin
proved to be as effective as sodium salicylate without the
irritation of phenolic compound.
 Aspirin however hydrolyzed to salicylic acid in the alkaline
media of the intestine by esterase enzyme.
substitution)
Esterification
 Aspirin is prepared in our lab by acetylating of salicylic acid
with acetic anhydride in the presence of H2SO4 as catalyst.
Procedure:
1-Place 3 gm of salicylic acid in 100 ml E.f. and add with constant stirring 6 ml
of acetic anhydride followed by 1 ml of conc. H2SO
2- Stir the mixture gently observing the rise in temp. to 70-80 oC.
While the salicylic acid dissolves, after 15 minutes the solution cools by itself
and a solid mass of aspirin forms
3-Pour 35 ml of ice-cold water over the contents of the flask to hydrolyze
excess acetic anhydride and to complete the ppt of aspirin
4- Collect the crude aspirin using a Buchner funnel and wash with ice-cold
water, air-dry the product and calculate the yield
5- Perform FeCl3 test on produced aspirin
Identification test of
Aspirin:
 Ferric chloride test;
 The presence of phenolic group in a compound is indicated by
the formation of violet iron complex when treated with ferric
chloride solution
 Aspirin ------------► give –ve result with FeCl3 due to absence of
phenolic group
 Salicylic acid--------► + ve result
 What is le chatelier’s principle?
 "If an equilibrium is subjected to a change of concentration, pressure or
temperature, the equilibrium shifts in the direction that trends to undo the
effect of the change”
 Why cold water is used in Aspirin washing?
 Aspirin, like many other substances, is more soluble in hot water than in cold water.
Therefore, to maximize the amount of crystals, it is best to cool the mixture as
much as possible.
 What are the methods which are used to assess
aspirin purity?
 Spectrophotometers are a reliable and economical way to keep the purity of Aspirin
consistent throughout the manufacturing process. The purity and amount of
acetylsalicylic acid in aspirin can be measured using a Visual Spectrophotometer.
Erythromycin
Streptomycin
(PRODUCTION & USE)
Introduction
Streptomycin:
Streptomycin is broad spectrum anti
-biotic (antimayobacterial) belonging to
oligosaccharides antibiotic or aminoglycoside
family.
It is active against gram negitive bacteria.
Uses
A number of bacterial infections can be treated by streptomycin. Such as:
 Tuberculosis
 Mayobacteriumavium complex
 Endocarditis
 Brucellosis
 Burkholderia infection
 Plague
 Tularemia
 Rat bite
 Streptomycin is active against Gram negitive bacteria. It is used to
treat Tuberculosis caused by Mycobacterium tuberculi.
 It is also used therapeutically in thr treatment of infectious diseases
caused by Gram negitive bacteria, specially organisms which are
resistant to penicillin.
 Prolonged treatment by Streptomycin at high dose can produce
neurotoxic reactions such as hearing impairment, los of balance
maintenance in man.
Origin of
streptomycin
Streptomyces griseus-
belongs to genus Streptomyces
commonly found in soil.
It is gram positive bacteria.
It is well known producer of antibiotic
and secondary metabolites.
Streptomyces griseus under
microscope
 They produce grey spore masses and grey-yellow reverse pigments when
they grow as colonies.
 The specification of this organism is that it grows in wide range pH ( from 5
to 11).
History
 Streptomycin was first isolated on October 19,1943 by Albert Schartz, a
PHD student on laboratory of Selman Abraham Waksman at Rutgers
University.
 Waksman and his laboratory staff discovered several antibiotics including
actinomycin , clavacin,streptothricin,neomycin etc.
 Streptomycin was first antibiotic cure for Tuberculosis.
Mechanism of action
Streptomycin is protein synthesis inhibitor.
It binds the 16S rRNA of 30S subunit of bacterial ribosome,interfering with binding of
formyl-methionyl tRNA to 30S subunit.
This leads the complete or partial inhibition of protein synthesis and eventually
death of microbial cells.
Human have ribosomes which are structurally different from that of bacteria,so
drugs does not have any effect on human cells.
Biosynthesis of Streptomycin
 In biosynthesis of streptomycin more tha 30 enzymatic steps are identified.
 Glucose 6-phosphate takes 3 independent routes to produce streptidine 6-
phosphate,L-dehydrostreptose and N-methyl glucosamine.
 The former two compounds condense to give an intermediate which combines
with methyl glucosamine to produce dihydro-streptomycin-6-phosphate.
Streptomycin is directly derived from glucose.
Though the enzymes involved in the synthesis of
N-methyl glucosamine are not yet known, it is
expected that about 30 enzymes take part in
the conversion of glucose into streptomycin
 Woodruff and Mc Daniel (1954) suggested medium consisting of soyabean meal
(1%), glucose 1% and sodium chloride (0.5%), Hocken hull (1963) recommended
the medium consisting of glucose (2.5%), soyabean meal (4.0%), distillers dry
soluble (0.5%) and sodium chloride (0.25%) and pH 7.3-7.5 for production of
streptomycin by S. griseus.
This process involves following 3 steps:
 Innoculum production
 Preparation of media
 Fermentation
 Harvest and recovery
 Byproduct
1-Innoculum production
 Spores of S. griseus maintained as soil stocks or lyophilized in a carrier such
as sterile skimmed milk, is employed as stock culture. The spores from
these stock cultures are then transferred to a sporulation medium to
provide enough sporulated growth to initiate liquid culture build-up of
mycelial inoculum in flasks or inoculum tanks. After sufficient mycelial
growth, it is fed to production fermenter.
2-Preparation of media
 A production medium contains carbon source and nitrogen source. Glucose is one of
the best carbon sources which helps in the greater yield of streptomycin, because it
provides basic carbon skeleton for the streptomycin production. Apart from glucose,
fructose, maltose, lactose, galactose, mannitol, xylose and starch can also be used as
carbon source. Polysaccharides and oligosaccharides generally give low yields.
 Peptones, soya extracts, meat extract, the residue from alcohol distillation, ammonium
salts, nitrates and glycine may be used as nitrogen source. Magnesium, calcium,
potassium, boron and molybdenum may be used as mineral source along with
sulphates, phosphates and chloride
 Phenylacetic acid, L-naphthalene acetic acid may be added as growth
stimulating compounds. It is better to add proline into the medium which helps in
high streptomycin production. Fats, oils and fatty acids may also be used along
with glucose. If necessary antioxidants such as sodium sulphate or starch or agar
may also be added into the medium. There is no need of precursor in the
production of streptomycin.
3-Fermentation
 Sterilized liquid medium with all the above substances is fed to the production fermenter.
Appropriate volume of inoculum (4-5%) is introduced into it. The optimum fermentation
temperature is in the range of 25 to 30°C and the optimum pH range is between 7.0 and 8.0.
High rate of streptomycin production, however, occurs in the pH range of 7.6 to 8.0.
 The process of fermentation is highly aerobic and lasts approximately for 5 to 7 days and
passes through 3 phases:
It takes about 24 hours to 48 hours. Rapid
growth and formation of abundant
mycelium occurs during this phase. The pH
rises to 8.0 due to release of ammonia into
medium, due to proteolytic activity of S.
griseus. Glucose is utilized slowly and little
production of streptomycin is witnessed.
(a) The First Phase
(b) The Second Phase:
It lasts for 2 days. Streptomycin
production takes place at a rapid rate
without increase in the mycelial growth.
The ammonia released in the first phase
is utilized, which results in the decrease
of pH to 7.6-8.0. Glucose and oxygen
are required in large quantity during this
phase.
(c) Third Phase:
Cells undergo lysis, releasing ammonia
and increase in the pH, which falls
again after a period of continuous
streptomycin production. Requirement
of oxygen decreases and the contents
of the medium including sugar get
exhausted. Finally streptomycin
production ceases. A yield of 1200
micrograms per milliliter of
streptomycin is obtained.
(iv) Harvest and Recovery:
After completion of fermentation the
mycelium is separated from the broth
by filtration. Streptomycin is recovered
by several methods.
But the one which is generally
employed is described below:
The fermentation broth is acidified, filtered and
neutralized. It is then passed through a column
containing a cation exchange resin to adsorb
the streptomycin from the broth. The column is
then washed with water and the antibiotic is
eluted with hydrochloric acid or cyclohexanol
or phosphoric acid. It is then concentrated at
about 60°C under vacuum.
The streptomycin is then dissolved in methanol and
filtered and acetone is added to the filtrate to
precipitate the antibiotic. The precipitate is again
washed with acetone and vacuum dried. It is
purified further by dissolving in methanol. The
streptomycin in pure form is extracted as calcium
chloride complex.
(v) Byproduct Vitamin B12:
Vitamin B12 is produced as a byproduct which
will not affect adversely the yield of
streptomycin.
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93

MID SYLLABUS INDUSTRIAL PROCESS.pdf

  • 1.
    Classification of Pharmaceutical productsand processing  classification of pharmaceuticaldosage forms  solids  semi solids  liquid forms  gas forms
  • 2.
     solids maybetablets and capsules.  semi solids are in cream,gel or in pate form.  liquid are in syrup or in solution form.  gas maybe inhalers or in aerosol form. SOLID FORM oral solid dosage forms are some of the most popular and convenient methods of drug delivery. They can be produced in a non-sterile environment with the high volume of products produced in these dosage forms.
  • 3.
    TYPES OF SOLIDDOSAGE FORMS  TABLETS  CAPSULES  POWDER  LOZENGES
  • 4.
    TABLETS  They areunit solid dosage forms consisting of the active ingredient and suitable pharmaceutical expients. They may vary in size, shape, weight, hardness, thickness, disintegration and characteristics and in other aspects. CAPSULES: They are unit solid dosage forms of consisting of gelatin shell that breaks open after the capsule has been swallowed and releasing the drug.
  • 5.
    CAPSULES  TYPES  Hard-shellgelatin capsule  Soft-shell gelatin capsule  1. SOFT GELATIN;  Manufactured in one piece with drug usually in liquid form inside the shell e.g;fat soluble vitamins and E etc.
  • 6.
    2. HARD SHELL Manufactured in two pieces that fit together and hold the drug, either in powdered or granular form.  LOZENGES  Tablets formed from hardened base or sugar and water containing drug and other flavors.  they are designed to dissolve slowly in the mouth and release the drug topically to the tissues of mouth and throat they are not to be swallowed.
  • 7.
    POWDER  They arebulk solid dosage forms consisting of two or more medicament meant for internal use.  The size of the powder determines the effective physiological properties. SEMI-SOLID FORMS They contain both liquid and solid dosage forms that are too soft in structure to quality for solids but too thick to be considered liquid. They are meant for typical application.
  • 8.
    PHARMACEUTICAL PROCESS It isthe formation of drugs which involves the unit operations. Types of unit operation i. Size reduction ii. Blending iii. Drying iv. Tablet compression v. Coating vi. Dry granulation
  • 9.
    Equipment’ s Used i.Drying equipment ii. Tablet machine iii. quality control machine iv. Coating machine v. Granulator vi. Weighting machine vii. Mixing equipment’ s viii. Size reduction equipment
  • 10.
    Steps involved intablet formation  Active pharmaceutical ingredients are bulk drugs that are pharmaceutically active and generate a desired pharmacological effects. Excipients:  They are pharmaceutically inactive and they act as a carrier .
  • 11.
    POWDER BLENDING  Powderare mixed using a blender to obtain to obtain a uniform and homogenous powder.  A wide range of excipients may be blended to create the final blend used to manufacture the solid dosage form in pharmaceutical industry.
  • 12.
    GRANULATION PROCESS  Granulationprocess transfers fine powder into the free flowing ,dust free granules that are easy to compress.  There are three methods of Granulations  Wet Granulation  Dry Granulations  Direct Granulations
  • 13.
    WET Granulations  Itis a widely used methods for the production of compressed.  It is essentially a process of size enlargement  Greater probability of meeting the physical requirements for tablet formation
  • 14.
    DRY GRANULATION  Theformation of granules by compacting powder mixtures into large pieces or compacts which is subsequently broken down or sized into granules is a possible granulation methods.  It is not widely used methods.  It is generally achieved by roller compaction.
  • 15.
    DIRECT GRANULATION  DirectCompression involves the direct compression of powdered materials into tablets without modifying the physical nature of the materials itself.  It has great importance because it is cheapest ones.  It also avoids many problems.
  • 16.
    DRYING AND DRYSCREENING  .Screened wet granules need to be dried for a particular time period in a fluid bed dryer at controlled temperature not exceeding 55C.  TABLET COMPRESSION :  This step involves in the compression of granules into a flat or convex ,round or unique shaped tablets.
  • 17.
    COATING  Tablets arecoated if there is need to mask the unpleasant taste or odour of some drud substances.
  • 18.
    Defects in compressiontablets i. Poor mixing ii. Low hardness iii. Weight variation
  • 19.
  • 21.
    Paracetamol also known asacetaminophen or APAP, is a medicine used to treat pain and fever. It is typically used for mild to moderate pain relief. Evidence for its use to relieve fever in children is mixed .It is often sold in combination with other medications, such as in many cold medications. In combination with opioid pain medication, paracetamol is also used for severe pain such as cancer pain and pain after surgery .It is typically used either by mouth or rectally, but is also available intravenously .Effects last between 2 and 4 hours.
  • 22.
    Chemical properties  Paracetamolmolecule polar surface area  Paracetamol electrostatic potential map  Paracetamol consists of a benzene ring core, substituted by one hydroxyl group and the nitrogen atom of an amide group in the para (1,4) pattern.[The amide group is acetamide (Ethan amide). It is an extensively conjugated system, as the lone pair on the hydroxyl oxygen, the benzene pi cloud, the nitrogen lone pair, the p orbital on the carbonyl carbon, and the lone pair on the carbonyl oxygen are all conjugated. The presence of two activating groups also make the benzene ring highly reactive toward electrophilic aromatic substitution. As the substituents are ortho, para-directing and para with respect to each other, all positions on the ring are more or less equally activated. The conjugation also greatly reduces the basicity of the oxygen's and the nitrogen, while making the hydroxyl acidic through delocalization of charge developed on the phenoxide anion.
  • 23.
    Synthesis of Paracetamol Inthe laboratory, paracetamol is easily prepared by nitrating phenol with sodium nitrate, separating the desired p-nitro phenol from the ortho- byproduct, and reducing the nitro group with sodium boro hydride. The resultant p-aminophenol is then acetylated with acetic anhydride. In this reaction, phenol is strongly activating, thus the reaction requires only mild conditions nitration The industrial process is analogous, but hydrogenation is used instead of the sodium boro hydride reduction
  • 24.
    Procedure 1. Add 2.1grams of 4-aminophenol into the round- bottomed flask. 2. Using your 25 mL measuring cylinder, measure 18 mL of water and add this to the flask. Add a magnetic follower to the round-bottomed flask. 3. Carefully clamp the flask at the neck and position it in the metal Dry Syn block which should be placed on the stirrer hotplate. Stir the reaction mixture using a magnetic follower. Do not apply heat at this stage . 4-. Assemble the apparatus for reflux as shown in the diagram below. Tip: Do not clamp the condenser
  • 25.
    5. Using aPasteur pipette, measure 3 mL of ethanoic anhydride (also known as acetic anhydride) into a 10 mL measuring cylinder. Add this to your mixture by lifting the condenser and adding directly to the round-bottomed flask. 6. Replace the condenser and switch on the heat to your hotplate (set the dial to about 120°C). Make sure there is water going through your condenser. 7. The reaction is heated at reflux for 15 minutes, stirring continuously. The reaction mixture should become colorless. 8. After refluxing for 15 minutes, switch off the heat
  • 26.
    11. filter theprecipitate (using a Buchner funnel), washing with small amounts of cold, distilled water. 12. After drying, the crude product should be placed in a clean 100cm3 conical flask and recrystallized by heating until it just dissolves in approximately 20ml of water. Cool the flask in ice until crystals of the purified paracetamol appear. Filter the crystals under vacuum, dry in a warm oven and then record the melting point and compare with standard paracetamol tablets (~170oC). Repeat recrystalisation process to achieve a more purer product
  • 27.
  • 28.
     Aspirin actas an analgesic, antipyretic (Something that reduces fever or quells it), Anti-inflammatory also inhibit platelet aggregation & prolongs bleeding time, because of its effect on G.I.T(gastrointestinal tract) it is contraindicated ( Anything (including a symptom or medical condition) that is a reason for a person to not receive a particular treatment or procedure because it may be harmful) in peptic ulcer, in this case we use paracetamol .  Aspirin is not given to children because is may cause raye’s syndrome.
  • 29.
    Introduction :  Aspirin(acetyl salicylic acid) is a widely used drug in modern society.  Salicylic acid which is a constituent of certain plant is itself an analgesic & was originally administered as sodium salicylate, since salicylic acid has an irritating effect on the stomach, chemists thought of a modification which would retain its properties while decreasing the adverse side effects.  Conversion to the ester satisfied this requirement& aspirin proved to be as effective as sodium salicylate without the irritation of phenolic compound.  Aspirin however hydrolyzed to salicylic acid in the alkaline media of the intestine by esterase enzyme.
  • 30.
  • 31.
    Esterification  Aspirin isprepared in our lab by acetylating of salicylic acid with acetic anhydride in the presence of H2SO4 as catalyst.
  • 32.
    Procedure: 1-Place 3 gmof salicylic acid in 100 ml E.f. and add with constant stirring 6 ml of acetic anhydride followed by 1 ml of conc. H2SO 2- Stir the mixture gently observing the rise in temp. to 70-80 oC. While the salicylic acid dissolves, after 15 minutes the solution cools by itself and a solid mass of aspirin forms 3-Pour 35 ml of ice-cold water over the contents of the flask to hydrolyze excess acetic anhydride and to complete the ppt of aspirin 4- Collect the crude aspirin using a Buchner funnel and wash with ice-cold water, air-dry the product and calculate the yield 5- Perform FeCl3 test on produced aspirin
  • 33.
    Identification test of Aspirin: Ferric chloride test;  The presence of phenolic group in a compound is indicated by the formation of violet iron complex when treated with ferric chloride solution  Aspirin ------------► give –ve result with FeCl3 due to absence of phenolic group  Salicylic acid--------► + ve result
  • 34.
     What isle chatelier’s principle?  "If an equilibrium is subjected to a change of concentration, pressure or temperature, the equilibrium shifts in the direction that trends to undo the effect of the change”  Why cold water is used in Aspirin washing?  Aspirin, like many other substances, is more soluble in hot water than in cold water. Therefore, to maximize the amount of crystals, it is best to cool the mixture as much as possible.  What are the methods which are used to assess aspirin purity?  Spectrophotometers are a reliable and economical way to keep the purity of Aspirin consistent throughout the manufacturing process. The purity and amount of acetylsalicylic acid in aspirin can be measured using a Visual Spectrophotometer.
  • 35.
  • 47.
  • 48.
    Introduction Streptomycin: Streptomycin is broadspectrum anti -biotic (antimayobacterial) belonging to oligosaccharides antibiotic or aminoglycoside family. It is active against gram negitive bacteria.
  • 49.
    Uses A number ofbacterial infections can be treated by streptomycin. Such as:  Tuberculosis  Mayobacteriumavium complex  Endocarditis  Brucellosis  Burkholderia infection  Plague  Tularemia  Rat bite
  • 50.
     Streptomycin isactive against Gram negitive bacteria. It is used to treat Tuberculosis caused by Mycobacterium tuberculi.  It is also used therapeutically in thr treatment of infectious diseases caused by Gram negitive bacteria, specially organisms which are resistant to penicillin.  Prolonged treatment by Streptomycin at high dose can produce neurotoxic reactions such as hearing impairment, los of balance maintenance in man.
  • 51.
    Origin of streptomycin Streptomyces griseus- belongsto genus Streptomyces commonly found in soil. It is gram positive bacteria. It is well known producer of antibiotic and secondary metabolites. Streptomyces griseus under microscope
  • 52.
     They producegrey spore masses and grey-yellow reverse pigments when they grow as colonies.  The specification of this organism is that it grows in wide range pH ( from 5 to 11).
  • 53.
    History  Streptomycin wasfirst isolated on October 19,1943 by Albert Schartz, a PHD student on laboratory of Selman Abraham Waksman at Rutgers University.  Waksman and his laboratory staff discovered several antibiotics including actinomycin , clavacin,streptothricin,neomycin etc.  Streptomycin was first antibiotic cure for Tuberculosis.
  • 54.
    Mechanism of action Streptomycinis protein synthesis inhibitor. It binds the 16S rRNA of 30S subunit of bacterial ribosome,interfering with binding of formyl-methionyl tRNA to 30S subunit. This leads the complete or partial inhibition of protein synthesis and eventually death of microbial cells. Human have ribosomes which are structurally different from that of bacteria,so drugs does not have any effect on human cells.
  • 55.
    Biosynthesis of Streptomycin In biosynthesis of streptomycin more tha 30 enzymatic steps are identified.  Glucose 6-phosphate takes 3 independent routes to produce streptidine 6- phosphate,L-dehydrostreptose and N-methyl glucosamine.  The former two compounds condense to give an intermediate which combines with methyl glucosamine to produce dihydro-streptomycin-6-phosphate.
  • 56.
    Streptomycin is directlyderived from glucose. Though the enzymes involved in the synthesis of N-methyl glucosamine are not yet known, it is expected that about 30 enzymes take part in the conversion of glucose into streptomycin
  • 57.
     Woodruff andMc Daniel (1954) suggested medium consisting of soyabean meal (1%), glucose 1% and sodium chloride (0.5%), Hocken hull (1963) recommended the medium consisting of glucose (2.5%), soyabean meal (4.0%), distillers dry soluble (0.5%) and sodium chloride (0.25%) and pH 7.3-7.5 for production of streptomycin by S. griseus.
  • 58.
    This process involvesfollowing 3 steps:  Innoculum production  Preparation of media  Fermentation  Harvest and recovery  Byproduct
  • 59.
    1-Innoculum production  Sporesof S. griseus maintained as soil stocks or lyophilized in a carrier such as sterile skimmed milk, is employed as stock culture. The spores from these stock cultures are then transferred to a sporulation medium to provide enough sporulated growth to initiate liquid culture build-up of mycelial inoculum in flasks or inoculum tanks. After sufficient mycelial growth, it is fed to production fermenter.
  • 60.
    2-Preparation of media A production medium contains carbon source and nitrogen source. Glucose is one of the best carbon sources which helps in the greater yield of streptomycin, because it provides basic carbon skeleton for the streptomycin production. Apart from glucose, fructose, maltose, lactose, galactose, mannitol, xylose and starch can also be used as carbon source. Polysaccharides and oligosaccharides generally give low yields.  Peptones, soya extracts, meat extract, the residue from alcohol distillation, ammonium salts, nitrates and glycine may be used as nitrogen source. Magnesium, calcium, potassium, boron and molybdenum may be used as mineral source along with sulphates, phosphates and chloride
  • 61.
     Phenylacetic acid,L-naphthalene acetic acid may be added as growth stimulating compounds. It is better to add proline into the medium which helps in high streptomycin production. Fats, oils and fatty acids may also be used along with glucose. If necessary antioxidants such as sodium sulphate or starch or agar may also be added into the medium. There is no need of precursor in the production of streptomycin.
  • 62.
    3-Fermentation  Sterilized liquidmedium with all the above substances is fed to the production fermenter. Appropriate volume of inoculum (4-5%) is introduced into it. The optimum fermentation temperature is in the range of 25 to 30°C and the optimum pH range is between 7.0 and 8.0. High rate of streptomycin production, however, occurs in the pH range of 7.6 to 8.0.  The process of fermentation is highly aerobic and lasts approximately for 5 to 7 days and passes through 3 phases:
  • 63.
    It takes about24 hours to 48 hours. Rapid growth and formation of abundant mycelium occurs during this phase. The pH rises to 8.0 due to release of ammonia into medium, due to proteolytic activity of S. griseus. Glucose is utilized slowly and little production of streptomycin is witnessed. (a) The First Phase
  • 64.
    (b) The SecondPhase: It lasts for 2 days. Streptomycin production takes place at a rapid rate without increase in the mycelial growth. The ammonia released in the first phase is utilized, which results in the decrease of pH to 7.6-8.0. Glucose and oxygen are required in large quantity during this phase.
  • 65.
    (c) Third Phase: Cellsundergo lysis, releasing ammonia and increase in the pH, which falls again after a period of continuous streptomycin production. Requirement of oxygen decreases and the contents of the medium including sugar get exhausted. Finally streptomycin production ceases. A yield of 1200 micrograms per milliliter of streptomycin is obtained.
  • 66.
    (iv) Harvest andRecovery: After completion of fermentation the mycelium is separated from the broth by filtration. Streptomycin is recovered by several methods. But the one which is generally employed is described below:
  • 67.
    The fermentation brothis acidified, filtered and neutralized. It is then passed through a column containing a cation exchange resin to adsorb the streptomycin from the broth. The column is then washed with water and the antibiotic is eluted with hydrochloric acid or cyclohexanol or phosphoric acid. It is then concentrated at about 60°C under vacuum.
  • 68.
    The streptomycin isthen dissolved in methanol and filtered and acetone is added to the filtrate to precipitate the antibiotic. The precipitate is again washed with acetone and vacuum dried. It is purified further by dissolving in methanol. The streptomycin in pure form is extracted as calcium chloride complex. (v) Byproduct Vitamin B12: Vitamin B12 is produced as a byproduct which will not affect adversely the yield of streptomycin.
  • 69.
  • 70.
  • 71.
  • 72.
  • 73.
  • 74.
  • 75.
  • 76.
  • 77.
  • 78.
  • 79.
  • 80.
  • 81.
  • 82.
  • 83.
  • 84.
  • 85.
  • 86.
  • 87.
  • 88.
  • 89.
  • 90.
  • 91.
  • 92.
  • 93.